SCHEMBL16629928

SCHEMBL16629928

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cccc5c4oc4ccc(-c6cccc7ccc8cccnc8c67)cc45)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
PTPRF P10586 1/20 0.34
PTPN2 P17706 1/20 0.34
PTPN1 P18031 1/20 0.34
GRM4 Q14833 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 2/20 0.33
TSHR P16473 2/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
PRKDC P78527 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21622665 0.93 ALOX5 (0.43) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL16629734 0.91 PIM1 (0.37) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL16629750 0.91 PIM1 (0.35) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL21622666 0.87 PIM1 (0.41) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL21622577 0.85 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL21622822 0.85 PIM1 (0.41) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL25497860 0.85 ALOX5 (0.34) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL16629652 0.85 ALOX5 (0.39) ALOX5GRM4KDM4EMAPTALDH1A1
SCHEMBL25620713 0.85 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL16629927 0.85 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10407394-B2 Triarylamine-substituted benzo[H]quinoline-derivatives as materials for electronic devices MERCK PATENT GMBH (DE) 2019-09-10 US disclosed
US-20160214942-A1 TRIARYLAMINE-SUBSTITUTED BENZO[H]QUINOLINE-DERIVATIVES AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-07-28 US disclosed
US-20160214942-A1 TRIARYLAMINE-SUBSTITUTED BENZO[H]QUINOLINE-DERIVATIVES AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-07-28 US disclosed
WO-2015049022-A1 TRIARYLAMINE-SUBSTITUTED BENZO[H]QUINOLINE-DERIVATIVES AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214942-A1 TRIARYLAMINE-SUBSTITUTED BENZO[H]QUINOLINE-DERIVATIVES AS MATERIALS FOR ELECTRONIC DEVICES KCNQ1, KCNH1, KCNQ2 ALOX5 3677/4885PIM1 2392/4885CSNK2A2 1997/4885
US-10407394-B2 Triarylamine-substituted benzo[H]quinoline-derivatives as materials for electronic devices KCNQ1, KCNH1, KCNQ2 ALOX5 3677/4885PIM1 2392/4885CSNK2A2 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.